High Risk BCC of the Nose After Telmisartan Hydrochlorothiazide: Potential Role of Nitrosamine Contamination as Key Triggering Factor for Skin Cancer Development

Kordeva S, Marchev S, Batashki I, Tchernev G
{"title":"High Risk BCC of the Nose After Telmisartan Hydrochlorothiazide: Potential Role of Nitrosamine Contamination as Key Triggering Factor for Skin Cancer Development","authors":"Kordeva S, Marchev S, Batashki I, Tchernev G","doi":"10.15226/2378-1726/10/1/0011150","DOIUrl":null,"url":null,"abstract":"A 62-year-old male presented in the dermatology department with primary complaints of a 1-year-old lesion located in the right upper nose segment. He noticed the formation growing in size and changing its texture. The patient denies having allergies or any malignancy in any family member. He has arterial hypertension for which he takes bisoprolol 10 mg once in the morning, amlodipine 10 mg once in the evening, spironolactone 25 mg once in the morning, atorvastatin 20 mg once in the evening and from 5 years till present telmisartan/hydrochlorothiazide 80/12.5 mg once in the morning.For five years the patient took clonidine hydrochloride 0.15 mg once daily and for a year - prazosin 2mg once daily. Now the clonidine hydrochloride is administered when needed. The patient requested a physical examination and further therapeutic approach to be established. The dermatological examination showed an elevated large lesion with crusts and regular borders located in the right upper nasal region, in close proximity to the right eye [Figure 1]. The lesion was suspected clinically for basal cell carcinoma.","PeriodicalId":15481,"journal":{"name":"Journal of Clinical Research in Dermatology","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Research in Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15226/2378-1726/10/1/0011150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A 62-year-old male presented in the dermatology department with primary complaints of a 1-year-old lesion located in the right upper nose segment. He noticed the formation growing in size and changing its texture. The patient denies having allergies or any malignancy in any family member. He has arterial hypertension for which he takes bisoprolol 10 mg once in the morning, amlodipine 10 mg once in the evening, spironolactone 25 mg once in the morning, atorvastatin 20 mg once in the evening and from 5 years till present telmisartan/hydrochlorothiazide 80/12.5 mg once in the morning.For five years the patient took clonidine hydrochloride 0.15 mg once daily and for a year - prazosin 2mg once daily. Now the clonidine hydrochloride is administered when needed. The patient requested a physical examination and further therapeutic approach to be established. The dermatological examination showed an elevated large lesion with crusts and regular borders located in the right upper nasal region, in close proximity to the right eye [Figure 1]. The lesion was suspected clinically for basal cell carcinoma.
替米沙坦氢氯噻嗪后鼻子的高风险BCC:亚硝胺污染作为皮肤癌发展的关键触发因素的潜在作用
一名62岁男性在皮肤科就诊,主诉为右上鼻段1岁病变。他注意到地层在变大,结构也在改变。病人否认有过敏或任何恶性肿瘤的家庭成员。他有动脉高血压,他服用比索洛尔10毫克,早上一次,氨氯地平10毫克,晚上一次,螺内酯25毫克,早上一次,阿托伐他汀20毫克,晚上一次,从5年至今,他服用替米沙坦/氢氯噻嗪80/12.5毫克,早上一次。患者5年服用盐酸可乐定0.15 mg每日1次,1年服用哌唑嗪2mg每日1次。现在需要时使用盐酸可乐定。患者要求进行体格检查并确定进一步的治疗方法。皮肤病学检查显示,右上鼻区靠近右眼,可见一隆起的大病变,有结痂,边界规则[图1]。临床怀疑为基底细胞癌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信